Kir3 channel signaling complexes: Focus on opioid receptor signaling

Frontiers in Cellular Neuroscience

Volumn 8, Issue JULY, 2014, Pages

  Nagi, Karim ^a,b   Pineyro, Graciela ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Allosteric modulation; Analgesia; Bias; Functional selectivity; GIRK; Opioid; Signaling; Signaling complexes

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; NARCOTIC ANALGESIC AGENT; OPIATE RECEPTOR; PHOSPHOLIPASE A2; VOLTAGE GATED POTASSIUM CHANNEL;

ALLOSTERISM; ANALGESIA; ARTICLE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROSCIENCE; NEUROTRANSMITTER RELEASE; NOCICEPTION; SIGNAL TRANSDUCTION;

EID: 84904057742     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00186     Document Type: Article

References (172)

1. 2+ channels and spinal analgesia couple to alternative splicing. Nat. Neurosci. 13, 1249-1256. doi: 10.1038/ nn.2643.
2. Audet, N., Charfi, I., Mnie-Filali, O., Amraei, M., Chabot-Dore, A. J., Millecamps, M., et al. (2012). Differential association of receptor-Gbetagamma complexes with beta-arrestin2 determines recycling bias and potential for tolerance of delta opioid receptor agonists. J. Neurosci. 32, 4827-4840. doi: 10.1523/JNEUROSCI.3734-11.2012.
3. Audet, N., Gales, C., Archer-Lahlou, E., Vallieres, M., Schiller, P. W., Bouvier, M., et al. (2008). Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J. Biol. Chem. 283, 15078-15088. doi: 10.1074/jbc.M707941200.
4. Ballantyne, J. C., and Shin, N. S. (2008). Efficacy of opioids for chronic pain: a review of the evidence. Clin. J. Pain 24, 469-478. doi: 10.1097/AJP.0b013e3 1816b2f26.
5. Banks, M. L., Roma, P. G., Folk, J. E., Rice, K. C., and Negus, S. S. (2011). Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis. Psychopharmacology (Berl) 216, 431-439. doi: 10.1007/s00213-011-2235-2.
6. Bardoni, R., Tawfik, V. L., Wang, D., Francois, A., Solorzano, C., Shuster, S. A., et al. (2014). Delta opioid receptors presynaptically regulate cutaneous mechanosen-sory neuron input to the spinal cord dorsal horn. Neuron 81, 1312-1327. doi: 10.1016/j.neuron.2014.01.044.
7. + channel (GIRK). J. Biol. Chem. 285, 6179-6185. doi: 10.1074/jbc.M109. 085944.
8. Berlin, S., Tsemakhovich, V. A., Castel, R., Ivanina, T., Dessauer, C. W., Keren-Raifman, T., et al. (2011). Two distinct aspects of coupling between Galpha(i) protein and G protein-activated K+ channel (GIRK) revealed by fluorescently labeled Galpha(i3) protein subunits. J. Biol. Chem. 286, 33223-33235. doi: 10.1074/jbc.M111.271056.
9. Bettahi, I., Marker, C. L., Roman, M. I., and Wickman, K. (2002). Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J. Biol. Chem. 277,48282-48288. doi: 10.1074/jbc.M209599200.
10. Blednov, Y. A., Stoffel, M., Alva, H., and Harris, R. A. (2003). A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc. Natl. Acad. Sci. U.S.A. 100, 277-282. doi: 10.1073/pnas.012682399.
11. Blednov, Y. A., Stoffel, M., Chang, S. R., and Harris, R. A. (2001). GIRK2 deficient mice. Evidence for hyperactivity and reduced anxiety. Physiol. Behav. 74, 109-117. doi: 10.1016/S0031-9384(01)00555-8.
12. Bobeck, E. N., Chen, Q., Morgan, M. M., and Ingram, S. L. (2014). Contribution of adenylyl cyclase modulation of pre-and postsynaptic GABA neurotransmission to morphine antinociception and tolerance. Neuropsychopharmacology. doi: 10.1038/npp.2014.62. [Epub ahead ofprint].
13. Bonci, A., andWilliams, J. T. (1997). Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17, 796-803.
14. Bourne, H. R. (1997). How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9, 134-142. doi: 10.1016/S0955-0674(97)80054-3.
15. Broom, D. C., Nitsche, J. F., Pintar, J. E., Rice, K. C., Woods, J. H., and Traynor, J. R. (2002). Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. J. Pharmacol. Exp. Ther. 303, 723-729. doi: 10.1124/jpet.102.036525.
16. Bruchas, M. R., and Chavkin, C. (2010). Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210, 137-147. doi: 10.1007/s00213-010-1806-y
17. Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., et al. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J. Neurosci. 27, 11614-11623. doi: 10.1523/JNEUROSCI.3769-07.2007.
18. Bruehl, S., Denton, J. S., Lonergan, D., Koran, M. E., Chont, M., Sobey, C., et al. (2013). Associations between KCNJ6 (GIRK2) gene polymorphisms and pain-related phenotypes. Pain 154, 2853-2859. doi: 10.1016/j.pain.2013.08.026.
19. Bunemann, M., Frank, M., and Lohse, M. J. (2003). Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc. Natl. Acad. Sci. U.S.A. 100, 16077-16082. doi: 10.1073/pnas.2536719100.
20. Cao, J. L., Vialou, V. F., Lobo, M. K., Robison, A. J., Neve, R. L., Cooper, D. C., et al. Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons. Proc. Natl. Acad. Sci. U.S.A. 107, 17011-17016. doi: 10.1073/pnas.10100 77107.
21. Charbogne, P., Kieffer, B. L., and Befort, K. (2014). 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 76(Pt B), 204-217. doi: 10.1016/j.neuropharm.2013.08.028.
22. Cheng, P. Y., Wu, D., Soong, Y., McCabe, S., Decena, J. A., and Szeto, H. H. (1993). Role of mu 1-and delta-opioid receptors in modulation of fetal EEG and respiratory activity. Am. J. Physiol. 265, R433-R438.
23. Christie, M. J. (2008). Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br. J. Pharmacol. 154, 384-396. doi: 10.1038/bjp.2008.100.
24. Chung, M. K., Cho, Y. S., Bae, Y. C., Lee, J., Zhang, X., and Ro, J. Y. (2013). Peripheral G protein-coupled inwardly rectifying potassium channels are involved in delta-opioid receptor-mediated anti-hyperalgesia in rat masseter muscle. Eur. J. Pain 18, 29-38. doi: 10.1002/j.1532-2149.2013.00343.x
25. Chu Sin Chung, P., and Kieffer, B. L. (2013). Delta opioid receptors in brain function and diseases. Pharmacol. Ther. 140, 112-120. doi: 10.1016/j.pharmthera. 2013.06.003.
26. Ciruela, F., Fernandez-Duenas, V., Sahlholm, K., Fernandez-Alacid, L., Nicolau, J., Watanabe, M., et al. (2010). Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits. Eur. J. Neurosci. 32, 1265-1277. doi: 10.1111/j.1460-9568.2010.07356.x
27. Clancy, S. M., Boyer, S. B., and Slesinger, P. A. (2007). Coregulation of natively expressed pertussis toxin-sensitive muscarinic receptors with G-protein-activated potassium channels. J. Neurosci. 27, 6388-6399. doi: 10.1523/ JNEUROSCI.1190-07.2007.
28. Clancy, S. M., Fowler, C. E., Finley, M., Suen, K. F., Arrabit, C., Berton, F., et al. (2005). Pertussis-toxin-sensitive Galpha subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a het-erotrimeric G-protein-channel complex. Mol. Cell. Neurosci. 28, 375-389. doi: 10.1016/j.mcn.2004.10.009.
29. Codd, E. E., Carson, J. R., Colburn, R. W., Stone, D. J., Van Besien, C. R., Zhang, S. P., et al. (2009). JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. J. Pharmacol. Exp. Ther. 329, 241-251. doi: 10.1124/jpet.108. 146969.
30. + channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 2642-2647. doi: 10.1073/pnas.1109099109.
31. Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R., and Porreca, F. (1988). Direct dependence studies in rats with agents selective for different types of opioid receptor. J. Pharmacol. Exp. Ther. 246, 950-955.
32. Cruz, H. G., Ivanova, T., Lunn, M. L., Stoffel, M., Slesinger, P. A., and Luscher, C. Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 7, 153-159. doi: 10.1038/nn1181.
33. De Sarro, G. B., Marra, R., Spagnolo, C., and Nistico, G. (1992). Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats. Funct. Neurol. 7, 235-238.
34. Dewire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., et al. (2013). A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J. Pharmacol. Exp. Ther. 344, 708-717. doi: 10.1124/jpet.112.201616.
35. Do Carmo, G. P., Folk, J. E., Rice, K. C., Chartoff, E., Carlezon, W. A. Jr., and Negus, S. S. (2009). The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur. J. Pharmacol. 604, 58-65. doi: 10.1016/j.ejphar.2008.12.021.
36. Drake, C. T., Chavkin, C., and Milner, T. A. (2007). Opioid systems in the dentate gyrus. Prog. BrainRes. 163, 245-263. doi: 10.1016/S0079-6123(07)63015-5.
37. Falkenburger, B. H., Jensen, J. B., and Hille, B. (2010). Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells. J. Gen. Physiol. 135, 81-97. doi: 10.1085/jgp.200910344.
38. Fenalti, G., Giguere, P. M., Katritch, V., Huang, X. P., Thompson, A. A., Cherezov, V., et al. (2014). Molecular control of delta-opioid receptor signalling. Nature 506, 191-196. doi: 10.1038/nature12944.
39. Feng, P., Rahim, R. T., Cowan, A., Liu-Chen, L. Y., Peng, X., Gaughan, J., et al. (2006). Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit. Eur. J. Pharmacol. 534, 250-257. doi: 10.1016/j.ejphar.2006.01.048.
40. Fernandez-Alacid, L., Aguado, C., Ciruela, F., Martin, R., Colon, J., Cabanero, M. J., et al. (2009). Subcellular compartment-specific molecular diversity of pre-and post-synaptic GABA-activated GIRK channels in Purkinje cells. J. Neurochem. 110, 1363-1376. doi: 10.1111/j.1471-4159.2009.06229.x
41. Fernandez-Alacid, L., Watanabe, M., Molnar, E., Wickman, K., and Lujan, R. Developmental regulation of G protein-gated inwardly-rectifying K+ (GIRK/Kir3) channel subunits in the brain. Eur. J. Neurosci. 34, 1724-1736. doi: 10.1111/j.1460-9568.2011.07886.x
42. Finley, M., Arrabit, C., Fowler, C., Suen, K. F., and Slesinger, P. A. (2004). betaL-betaM loop in the C-terminal domain of G protein-activated inwardlyrectifying K(+) channels is important for G(betagamma) subunit activation. J. Physiol. 555, 643-657. doi: 10.1113/jphysiol.2003.056101.
43. Ford, C. E., Skiba, N. P., Bae, H., Daaka, Y., Reuveny, E., Shekter, L. R., et al. (1998). Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280, 1271-1274. doi: 10.1126/science.280.53 67.1271.
44. Fourie, C., Li, D., and Montgomery, J. M. (2014). The anchoring protein SAP97 influences the trafficking and localisation of multiple membrane channels. Biochim. Biophys. Acta 1838, 589-594. doi: 10.1016/j.bbamem.2013.03.015.
45. Gales, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hebert, T. E., et al. (2005). Real-time monitoring of receptor and G-protein interactions in living cells. Nat. Methods 2, 177-184. doi: 10.1038/nmeth743.
46. Gales, C., Van Durm, J. J., Schaak, S., Pontier, S., Percherancier, Y., Audet, M., et al. (2006). Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13, 778-786. doi: 10.1038/nsmb1134.
47. Gallantine, E. L., and Meert, T. F. (2005). A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80. Basic Clin. Pharmacol. Toxicol. 97, 39-51. doi: 10.1111/j.1742-7843.2005.pto_97107.x
48. Gao, X. F., Zhang, H. L., You, Z. D., Lu, C. L., and He, C. (2007). G protein-coupled inwardly rectifying potassium channels in dorsal root ganglion neurons. Acta Pharmacol. Sin. 28, 185-190. doi: 10.1111/j.1745-7254.2007.00478.x
49. Gaveriaux-Ruff, C., and Kieffer, B. L. (2011). Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav. Pharmacol. 22, 405-414. doi: 10.1097/FBP.0b013e32834a1f2c
50. Gendron, L., Lucido, A. L., Mennicken, F., O'Donnell, D., Vincent, J. P., Stroh, T., et al. (2006). Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J. Neurosci. 26, 953-962. doi: 10.1523/JNEUR0SCI.3598-05.2006.
51. Gilman, A. G. (1987). G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649. doi: 10.1146/annurev.bi.56.070187.003151.
52. Glaum, S. R., Miller, R. J., and Hammond, D. L. (1994). Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14, 4965-4971.
53. Goldenberg, D. L. (2010). Pain/Depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am. J. Med. 123, 675-682. doi: 10.1016/j.amjmed.2010.01.014.
54. Gonzalez-Rodriguez, S., Hidalgo, A., Baamonde, A., and Menendez, L. (2010). Involvement of Gi/o proteins and GIRK channels in the potentiation of morphine-induced spinal analgesia in acutely inflamed mice. Naunyn Schmiedeberg's Arch. Pharmacol. 381, 59-71. doi: 10.1007/s00210-009-0471-3.
55. Gonzalez-Rodriguez, S., Llames, S., Hidalgo, A., Baamonde, A., and Menendez, L. Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice. Fundam. Clin. Pharmacol. 26, 363-372. doi: 10.1111/j.1472-8206.2010.00921.x
56. Gross, W., and Lohse, M. J. (1991). Mechanism of activation ofA2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction. Mol. Pharmacol. 39, 524-530.
57. Gysling, K., and Wang, R. Y. (1983). Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 277, 119-127. doi: 10.1016/0006-8993(83)90913-7.
58. Han, M. H., Bolanos, C. A., Green, T. A., Olson, V. G., Neve, R. L., Liu, R. J., et al. (2006). Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J. Neurosci. 26, 4624-4629. doi: 10.1523/JNEUROSCI.4701-05.2006.
59. Hassan, A. H., Ableitner, A., Stein, C., and Herz, A. (1993). Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55, 185-195. doi: 10.1016/0306-4522(93)90465-R
60. He, C., Yan, X., Zhang, H., Mirshahi, T., Jin, T., Huang, A., et al. (2002). Identification of critical residues controlling G protein-gated inwardly rectifying K(+) channel activity through interactions with the beta gamma subunits of G proteins. J. Biol. Chem. 277, 6088-6096. doi: 10.1074/jbc.M104851200.
61. He, C., Zhang, H., Mirshahi, T., and Logothetis, D. E. (1999). Identification of a potassium channel site that interacts with G protein betagamma subunits to mediate agonist-inducedsignaling. J. Biol. Chem. 274, 12517-12524.
62. He, L., and Whistler, J. L. (2007). The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain. Pharmacology 79, 193-202. doi: 10.1159/000100893.
63. Hearing, M., Kotecki, L., Marron Fernandez De Velasco, E., Fajardo-Serrano, A., Chung, H. J., Lujan, R., et al. (2013). Repeated cocaine weakens GABA(B)-Girk signaling in layer 5/6 pyramidal neurons in the prelimbic cortex. Neuron 80, 159-170. doi: 10.1016/j.neuron.2013.07.019.
64. Hein, P., Frank, M., Hoffmann, C., Lohse, M. J., and Bunemann, M. (2005). Dynamics of receptor/G protein coupling in living cells. EMBO J. 24, 4106-4114. doi: 10.1038/sj.emboj.7600870.
65. Hein, P., Rochais, F., Hoffmann, C., Dorsch, S., Nikolaev, V. O., Engelhardt, S., et al. (2006). Gs activation is time-limiting in initiating receptor-mediated signaling. J. Biol. Chem. 281, 33345-33351. doi: 10.1074/jbc.M606713200.
66. Heinke, B., Gingl, E., and Sandkuhler, J. (2011). Multiple targets of mu-opioid receptor-mediated presynaptic inhibition at primary afferent Adelta-and C-fibers. J. Neurosci. 31, 1313-1322. doi: 10.1523/JNEUROSCI.4060-10.2011.
67. Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., and Kurachi, Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 90, 291-366. doi: 10.1152/physrev.00021.2009.
68. Hibino, H., Inanobe, A., Tanemoto, M., Fujita, A., Doi, K., Kubo, T., et al. (2000). Anchoring proteins confer G protein sensitivity to an inward-rectifier K(+) channel through the GK domain. EMBO J. 19, 78-83. doi: 10.1093/emboj/19.1.78.
69. Huang, C. L., Jan, Y. N., and Jan, L. Y. (1997). Binding of the G protein betagamma subunit to multiple regions of G protein-gated inward-rectifying K+ channels. FEBSLett. 405, 291-298. doi: 10.1016/S0014-5793(97)00197-X
70. Huang, C. L., Slesinger, P. A., Casey, P. J., Jan, Y. N., and Jan, L. Y. (1995). Evidence that direct binding of G beta gamma to the GIRK1. G protein-gated inwardlyrectifying K+ channel is important for channel activation. Neuron 15, 1133-1143.
71. Ikeda, K., Kobayashi, T., Kumanishi, T., Niki, H., and Yano, R. (2000). Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia. Neurosci. Res. 38, 113-116. doi: 10.1016/S0168-0102(00)00144-9.
72. Ikeda, K., Kobayashi, T., Kumanishi, T., Yano, R., Sora, I., and Niki, H. (2002). Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci. Res. 44, 121-131. doi: 10.1016/S0168-0102(02)00094-9
73. Inanobe, A., Yoshimoto, Y., Horio, Y., Morishige, K. I., Hibino, H., Matsumoto, S.,et al. (1999). Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci. 19, 1006-1017.
74. Ivanina, T., Rishal, I., Varon, D., Mullner, C., Frohnwieser-Steinecke, B., Schreibmayer, W., et al. (2003). Mapping the Gbetagamma-binding sites in GIRK1 and GIRK2 subunits of the G protein-activated K+ channel. J. Biol. Chem. 278, 29174-29183. doi: 10.1074/jbc.M304518200.
75. Ivanina, T., Varon, D., Peleg, S., Rishal, I., Porozov, Y., Dessauer, C. W., et al. (2004).Galphai1 and Galphai3 differentially interact with, and regulate, the G protein-activated K+ channel. J. Biol. Chem. 279, 17260-17268. doi: 10.1074/jbc.M313425200
76. Javed, R. R., Dewey, W. L., Smith, P. A., and Smith, F. L. (2004). PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice. Eur. J. Pharmacol. 492, 149-157. doi: 10.1016/j.ejphar.2004.03.061.
77. Jensen, J. B., Lyssand, J. S., Hague, C., and Hille, B. (2009). Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phos-phoinositides and Kv7.2/7.3. K+ channels. J. Gen. Physiol. 133, 347-359. doi: 10.1085/jgp.200810075.
78. Johnson, S. W., and North, R. A. (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488.
79. Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor heterodimeriza-tion modulates receptor function. Nature 399, 697-700.
80. Jutkiewicz, E. M., Baladi, M. G., Folk, J. E., Rice, K. C., and Woods, J. H. (2006). The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. J. Pharmacol. Exp. Ther. 317, 1337-1348. doi: 10.1124/jpet.105.095810.
81. Jutkiewicz, E. M., Rice, K. C., Traynor, J. R., and Woods, J. H. (2005). Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology (Berl) 182, 588-596. doi: 10.1007/s00213-005-0138-9.
82. Kalso, E., Edwards, J. E., Moore, R. A., and McQuay, H. J. (2004). Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112, 372-380. doi: 10.1016/j.pain.2004.09.019.
83. Kawano, T., Zhao, P., Floreani, C. V., Nakajima, Y., Kozasa, T., and Nakajima, S. (2007). Interaction of Galphaq and Kir3, G protein-coupled inwardly rectifying potassium channels. Mol. Pharmacol. 71, 1179-1184. doi: 10.1124/mol.106.032508.
84. Kenakin, T. (2008). Functional selectivity in GPCR modulator screening. Comb. Chem. High Throughput Screen. 11, 337-343. doi: 10.2174/1386207087 84534824
85. Kenakin, T., and Miller, L. J. (2010). Seven transmembrane receptors as shapeshift-ing proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265-304. doi: 10.1124/pr.108.000992.
86. Kenakin, T., and Onaran, O. (2002). The ligand paradox between affinity and efficacy: can you be there and not make a difference? Trends Pharmacol. Sci. 23, 275-280. doi: 10.1016/S0165-6147(02)02036-9.
87. Kieffer, B. L., and Gaveriaux-Ruff, C. (2002). Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285-306. doi: 10.1016/S0301-0082(02) 00008-4
88. Koyrakh, L., Lujan, R., Colon, J., Karschin, C., Kurachi, Y., Karschin, A., et al. (2005).Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J. Neurosci. 25,11468-11478. doi: 10.1523/JNEUROSCI.3484-05.2005
89. Krapivinsky, G., Kennedy, M. E., Nemec, J., Medina, I., Krapivinsky, L., and Clapham, D. E. (1998). Gbeta binding to GIRK4 subunit is critical for G protein-gated K+ channel activation. J. Biol. Chem. 273, 16946-16952. doi: 10.1074/jbc.273.27.16946.
90. Kunkel, M. T., and Peralta, E. G. (1995). Identification of domains conferring G protein regulation on inward rectifier potassium channels. Cell 83, 443-449. doi: 10.1016/0092-8674(95)90122-1.
91. Laurent, V., Leung, B., Maidment, N., and Balleine, B. W. (2012). Mu-and delta-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice. J. Neurosci. 32, 1875-1883. doi: 10.1523/JNEUROSCI.4688-11.2012.
92. Lavine, N., Ethier, N., Oak, J. N., Pei, L., Liu, F., Trieu, P., et al. (2002). G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277, 46010-46019. doi: 10.1074/jbc.M205035200.
93. Leach, K., Sexton, P. M., and Christopoulos, A. (2007). Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. Trends Pharmacol. Sci. 28, 382-389. doi: 10.1016/j.tips.2007.06.004.
94. Le Bourdonnec, B., Windh, R. T., Ajello, C. W., Leister, L. K., Gu, M., Chu, G. H., et al. (2008). Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4,-piperidine]-4-yl)benzamide (ADL5859). J. Med. Chem. 51, 5893-5896. doi: 10.1021/jm8008986
95. Le Merrer, J., Becker, J. A., Befort, K., and Kieffer, B. L. (2009). Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379-1412. doi: 10.1152/physrev.00005.2009.
96. Lemos, J. C., Roth, C. A., Messinger, D. I., Gill, H. K., Phillips, P. E., and Chavkin, C.(2012). Repeated stress dysregulates kappa-opioid receptor signaling in the dorsal raphe through a p38alpha MAPK-dependent mechanism. J. Neurosci. 32, 12325-12336. doi: 10.1523/JNEUROSCI.2053-12.2012.
97. Li, J. L., Ding, Y. Q., Li, Y. Q., Li, J. S., Nomura, S., Kaneko, T., et al. (1998). Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res. 794, 347-352. doi: 10.1016/S0006-8993(98)00332-1.
98. Liao, Y. J., Jan, Y. N., and Jan, L. Y. (1996). Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J. Neurosci. 16, 7137-7150.
99. Lober, R. M., Pereira, M. A., and Lambert, N. A. (2006). Rapid activation of inwardly rectifying potassium channels by immobile G-protein-coupled receptors. J. Neurosci. 26, 12602-12608. doi: 10.1523/JNEUROSCI.4020-06.2006
100. Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., and Clapham, D. E. (1987). The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325, 321-326. doi: 10.1038/325321a0.
101. Lohse, M. J., Nuber, S., and Hoffmann, C. (2012). Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling. Pharmacol. Rev. 64, 299-336. doi: 10.1124/pr.110.004309.
102. Lotsch, J., Pruss, H., Veh, R. W., and Doehring, A. (2010). A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size. Pharmacogenet. Genomics 20, 291-297. doi: 10.1097/FPC.0b013e3283386bda
103. Lujan, R., Marron Fernandez De Velasco, E., Aguado, C., and Wickman, K. (2014). New insights into the therapeutic potential of Girk channels. Trends Neurosci. 37, 20-29. doi: 10.1016/j.tins.2013.10.006.
104. Luscher, C., Jan, L. Y., Stoffel, M., Malenka, R. C., and Nicoll, R. A. (1997). G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynap-tic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19, 687-695. doi: 10.1016/S0896-6273(00)80381-5.
105. Luscher, C., and Slesinger, P. A. (2010). Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat. Rev. Neurosci. 11, 301-315. doi: 10.1038/nrn2834.
106. Luscher, C., and Ungless, M. A. (2006). The mechanistic classification of addictive drugs. PLoS Med. 3:e437. doi: 10.1371/journal.pmed.0030437.
107. Marker, C. L., Cintora, S. C., Roman, M. I., Stoffel, M., and Wickman, K. (2002). Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice. Neuroreport 13, 2509-2513. doi: 10.1097/00001756-200212200-00026.
108. Marker, C. L., Lujan, R., Colon, J., and Wickman, K. (2006). Distinct populations of spinal cord lamina II interneurons expressing G-protein-gated potassium channels. J. Neurosci. 26, 12251-12259. doi: 10.1523/JNEUROSCI.3693-06.2006
109. Marker, C. L., Lujan, R., Loh, H. H., and Wickman, K. (2005). Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect ofmu-and delta-but not kappa-opioids. J. Neurosci. 25, 3551-3559. doi: 10.1523/JNEUROSCI.4899-04.2005.
110. Marker, C. L., Stoffel, M., and Wickman, K. (2004). Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. J. Neurosci. 24, 2806-2812. doi: 10.1523/JNEUROSCI.5251-03.2004.
111. Mase, Y., Yokogawa, M., Osawa, M., and Shimada, I. (2012). Structural basis for modulation of gating property of G protein-gated inwardly rectifying potassium ion channel (GIRK) by i/o-family G protein alpha subunit (Galphai/o). J. Biol. Chem. 287, 19537-19549. doi: 10.1074/jbc.M112.353888.
112. McAllister, S. D., Griffin, G., Satin, L. S., and Abood, M. E. (1999). Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J. Pharmacol. Exp. Ther. 291,618-626
113. McLaughlin, J. P., Myers, L. C., Zarek, P. E., Caron, M. G., Lefkowitz, R. J., Czyzyk, T. A., et al. (2004). Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J. Biol. Chem. 279, 1810-1818. doi: 10.1074/jbc.M305796200.
114. Mitrovic, I., Margeta-Mitrovic, M., Bader, S., Stoffel, M., Jan, L. Y., and Basbaum, A. I. (2003). Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha2-adrenergic analgesia and analgesic sex differences. Proc. Natl. Acad. Sci. U.S.A. 100,271-276. doi: 10.1073/pnas.0136822100.
115. Mogil, J. S. (2009). Are we getting anywhere in human pain genetics? Pain 146, 231-232. doi: 10.1016/j.pain.2009.07.023.
116. Moore, S. D., Madamba, S. G., Schweitzer, P., and Siggins, G. R. (1994). Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J. Neurosci. 14, 809-820.
117. Morgan, M. M., and Christie, M. J. (2011). Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br. J. Pharmacol. 164, 1322-1334. doi: 10.1111/j.1476-5381.2011.01335.x
118. Nassirpour, R., Bahima, L., Lalive, A. L., Luscher, C., Lujan, R., and Slesinger, P. (2010). Morphine-and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J. Neurosci. 30, 13419-13430. doi: 10.1523/JNEUROSCI.2966-10.2010.
119. + channels. Science 272, 1950-1953. doi: 10.1126/science.272.5270.1950.
120. Neer, E. J. (1995). Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80, 249-257. doi: 10.1016/0092-8674(95)90407-7.
121. Neubig, R. R. (1994). Membrane organization in G-protein mechanisms. FASEB J. 8, 939-946.
122. Nishizawa, D., Nagashima, M., Katoh, R., Satoh, Y., Tagami, M., Kasai, S., et al. (2009). Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS ONE 4:e7060. doi: 10.1371/journal.pone.0007060.
123. Nobles, M., Benians, A., and Tinker, A. (2005). Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc. Natl. Acad. Sci. U.S.A. 102, 18706-18711. doi: 10.1073/pnas.0504778102.
124. Nockemann, D., Rouault, M., Labuz, D., Hublitz, P., McKnelly, K., Reis, F. C., et al. (2013). The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol. Med. 5, 1263-1277. doi: 10.1002/emmm.201201980.
125. Obara, I., Parkitna, J. R., Korostynski, M., Makuch, W., Kaminska, D., Przewlocka,et al. (2009). Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141, 283-291. doi: 10.1016/j.pain.2008.12.006.
126. Orly, J., and Schramm, M. (1976). Coupling of catecholamine receptor from one cell with adenylate cyclase from another cell by cell fusion. Proc. Natl. Acad. Sci. U.S.A. 73, 4410-4414. doi: 10.1073/pnas.73.12.4410.
127. Padgett, C. L., Lalive, A. L., Tan, K. R., Terunuma, M., Munoz, M. B., Pangalos, M. N., et al. (2012). Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron 73, 978-989. doi: 10.1016/j.neuron.2011.12.031.
128. Patil, N., Cox, D. R., Bhat, D., Faham, M., Myers, R. M., and Peterson, A. S. (1995). A potassium channel mutation in weaver mice implicates membrane excitabilityin granule cell differentiation. Nat. Genet. 11, 126-129. doi: 10.1038/ ng1095-126.
129. Pert, C. B., and Snyder, S. H. (1973). Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014. doi: 10.1126/science.179.4077.1011.
130. Pradhan, A. A., Befort, K., Nozaki, C., Gaveriaux-Ruff, C., and Kieffer, B. L. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol. Sci. 32, 581-590. doi: 10.1016/j.tips.2011.06.008.
131. Pradhan, A. A., Walwyn, W., Nozaki, C., Filliol, D., Erbs, E., Matifas, A., et al. (2010). Ligand-directed trafficking of the delta-opioid receptor in vivo: two paths toward analgesic tolerance. J. Neurosci. 30, 16459-16468. doi: 10.1523/JNEURQSCI.3748-10.2010.
132. Pravetoni, M., and Wickman, K. (2008). Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes Brain Behav. 7, 523-531. doi: 10.1111/j.1601-183X.2008.00388.x
133. Raehal, K. M., Walker, J. K., and Bohn, L. M. (2005). Morphine side effects in beta-arrestin 2 knockout mice. J. Pharmacol. Exp. Ther. 314, 1195-1201. doi: 10.1124/jpet.105.087254.
134. Rasmussen, S. G., Devree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S.,et al. (2011). Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477, 549-555. doi: 10.1038/nature10361.
135. Raveh, A., Riven, I., and Reuveny, E. (2009). Elucidation of the gating of the GIRK channel using a spectroscopic approach. J. Physiol. 587, 5331-5335. doi: 10.1113/jphysiol.2009.180158.
136. Rebois, R. V., Robitaille, M., Gales, C., Dupre, D. J., Baragli, A., Trieu, P., et al. (2006). Heterotrimeric G proteins form stable complexes with adeny-lyl cyclase and Kir3.1 channels in living cells. J. Cell Sci. 119, 2807-2818. doi: 10.1242/jcs.03021.
137. Richard-Lalonde, M., Nagi, K., Audet, N., Sleno, R., Amraei, M., Hogue, M., et al. Conformational dynamics ofKir3.1/Kir3.2 channel activation via delta-opioid receptors. Mol. Pharmacol. 83, 416-428. doi: 10.1124/mol.112.081950.
138. Riven, I., Iwanir, S., and Reuveny, E. (2006). GIRK channel activation involves a local rearrangement of a preformed G protein channel complex. Neuron 51, 561-573. doi: 10.1016/j.neuron.2006.08.017.
139. Robitaille, M., Ramakrishnan, N., Baragli, A., and Hebert, T. E. (2009). Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes. Cell. Signal. 21, 488-501. doi: 10.1016/j.cellsig.2008.11.011.
140. Romero, G., Von Zastrow, M., and Friedman, P. A. (2011). Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity. Adv. Pharmacol. 62, 279-314. doi: 10.1016/B978-0-12-385952-5.00003-8.
141. Rusinova, R., Mirshahi, T., and Logothetis, D. E. (2007). Specificity of Gbetagamma signaling to Kir3 channels depends on the helical domain of pertussis toxin-sensitive Galpha subunits. J. Biol. Chem. 282, 34019-34030. doi: 10.1074/jbc.M704928200.
142. Saenz Del Burgo, L., Cortes, R., Mengod, G., Zarate, J., Echevarria, E., and Salles, J. Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain. J. Comp. Neurol. 510, 581-606. doi: 10.1002/cne.21810.
143. Saitoh, A., Sugiyama, A., Nemoto, T., Fujii, H., Wada, K., Oka, J., et al. (2011). The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav. Brain Res. 223, 271-279. doi: 10.1016/j.bbr.2011.04.041.
144. Scherrer, G., Imamachi, N., Cao, Y. Q., Contet, C., Mennicken, F., O'Donnell, D, et al. (2009). Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137, 1148-1159. doi: 10.1016/j.cell.2009. 04.019.
145. Schreibmayer, W., Dessauer, C. W., Vorobiov, D., Gilman, A. G., Lester, H. A., Davidson, N., et al. (1996). Inhibition of an inwardly rectifying K+ channel by G-protein alpha-subunits. Nature 380, 624-627. doi: 10.1038/380624a0.
146. Signorini, S., Liao, Y. J., Duncan, S. A., Jan, L. Y., and Stoffel, M. (1997). Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardlyrectifying K+ channel GIRK2. Proc. Natl. Acad. Sci. U.S.A. 94, 923-927. doi: 10.1073/pnas.94.3.923.
147. Simon, E. J., Hiller, J. M., and Edelman, I. (1973). Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70, 1947-1949. doi: 10.1073/pnas.70.7.1947.
148. Stein, C., Millan, M. J., Shippenberg, T. S., Peter, K., and Herz, A. (1989). Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248, 1269-1275.
149. Tavani, A., Petrillo, P., La Regina, A., and Sbacchi, M. (1990). Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats. J. Pharmacol. Exp. Ther. 254, 91-97.
150. Tian, W. N., Duzic, E., Lanier, S. M., and Deth, R. C. (1994). Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol. Pharmacol. 45, 524-531.
151. Tolkovsky, A. M., and Levitzki, A. (1978). Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry 17, 3795. doi: 10.1021/bi00611a020.
152. Urban, J. D., Clarke, W. P., Von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., et al. (2007). Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1-13. doi: 10.1124/jpet.106.104463.
153. Vadivelu, N., Mitra, S., and Hines, R. L. (2011). Peripheral opioid receptor agonists for analgesia: a comprehensive review. J. Opioid Manag. 7, 55-68. doi: 10.5055/jom.2011.0049.
154. Van't Veer, A., and Carlezon, W. A. Jr. (2013). Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl.) 229, 435-452. doi: 10.1007/s00213-013-3195-5.
155. Vaughan, C. W., and Christie, M. J. (1997). Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 498(Pt 2), 463-472.
156. Vaughan, C. W., Ingram, S. L., Connor, M. A., and Christie, M. J. (1997). How opioids inhibit GABA-mediated neurotransmission. Nature 390, 611-614. doi: 10.1038/37610.
157. Vilardaga, J. P., Bunemann, M., Krasel, C., Castro, M., and Lohse, M. J. (2003). Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat. Biotechnol. 21, 807-812. doi: 10.1038/nbt838.
158. Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E. et al. (2005). A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc. Natl. Acad. Sci. U.S.A. 102, 9050-9055. doi: 10.1073/pnas.0501112102.
159. Wang, H. B., Zhao, B., Zhong, Y. Q., Li, K. C., Li, Z. Y., Wang, Q., et al. (2010). Coexpression of delta-and mu-opioid receptors in nociceptive sensoryneurons. Proc. Natl. Acad. Sci. U.S.A. 107, 13117-13122. doi: 10.1073/pnas.1008382107.
160. Wei, Z. Y., Karim, F., and Roerig, S. C. (1996). Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 278, 1392-1407.
161. Whorton, M. R., and MacKinnon, R. (2011). Crystal structure of the mammalian GIRK2. K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147, 199-208. doi: 10.1016/j.cell.2011.07.046.
162. Whorton, M. R., and MacKinnon, R. (2013). X-ray structure of the mammalian GIRK2-betagamma G-protein complex. Nature 498, 190-197. doi: 10.1038/nature12241.
163. Wickman, K., Karschin, C., Karschin, A., Picciotto, M. R., and Clapham, D. E. (2000). Brain localization and behavioral impact of the G-protein-gated K+ channel subunit GIRK4. J. Neurosci. 20, 5608-5615.
164. Wickman, K., Nemec, J., Gendler, S. J., and Clapham, D. E. (1998). Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20, 103-114. doi: 10.1016/S0896-6273(00)80438-9.
165. Wickman, K. D., Iniguez-Lluhl, J. A., Davenport, P. A., Taussig, R., Krapivinsky, G., Linder, M. E., et al. (1994). Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel. Nature 368, 255-257. doi: 10.1038/368255a0.
166. Wimpey, T. L., and Chavkin, C. (1991). Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 6, 281-289. doi: 10.1016/0896-6273(91) 90363-5.
167. Wreggett, K. A., and De Lean, A. (1984). The ternarycomplexmodel. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitarygland. Mol. Pharmacol. 26, 214-227.
168. Wrigley, P. J., Jeong, H. J., and Vaughan, C. W. (2010). Dissociation of mu-and delta-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Mol. Pain 6:71. doi: 10.1186/1744-8069-6-71.
169. 2+ currents. Neuroscience 153, 1256-1267. doi: 10.1016/j.neuroscience.2008.03.031.
170. Xu, M., Petraschka, M., McLaughlin, J. P., Westenbroek, R. E., Caron, M. G., Lefkowitz, R. J., et al. (2004). Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J. Neurosci. 24, 4576-4584. doi: 10.1523/JNEUROSCI.5552-03.2004.
171. Yang, H. Y., Wu, Z. Y., Wood, M., Whiteman, M., and Bian, J. S. (2014). Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway. Antioxid. RedoxSignal. 20, 31-41. doi: 10.1089/ars.2012.5119.
172. Yokogawa, M., Osawa, M., Takeuchi, K., Mase, Y., and Shimada, I. (2011). NMR analyses of the Gbetagamma binding and conformational rearrangements of the cytoplasmic pore of G protein-activated inwardly rectifying potassium channel 1 (GIRK1). J. Biol. Chem. 286, 2215-2223. doi: 10.1074/jbc.M110.160754